|
HLCS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.79314374249407E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.90259999555931E-08 |
| Normal-vs-Stage2 |
2.94399999933859E-08 |
| Normal-vs-Stage3 |
2.11239914449379E-11 |
| Normal-vs-Stage4 |
2.68729483110519E-11 |
| Stage1-vs-Stage2 |
4.985900E-02 |
| Stage1-vs-Stage3 |
2.875300E-03 |
| Stage1-vs-Stage4 |
6.765600E-04 |
| Stage2-vs-Stage3 |
5.862200E-01 |
| Stage2-vs-Stage4 |
2.270200E-01 |
| Stage3-vs-Stage4 |
4.724200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83897341798911E-12 |
| Normal-vs-AfricanAmerican |
1.422790E-04 |
| Normal-vs-Asian |
6.536000E-02 |
| Caucasian-vs-AfricanAmerican |
4.423600E-01 |
| Caucasian-vs-Asian |
6.083400E-01 |
| AfricanAmerican-vs-Asian |
9.112200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.57671661785253E-12 |
| Normal-vs-Female |
1.02940000967777E-09 |
| Male-vs-Female |
4.584600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.571600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.40569997256301E-09 |
| Normal-vs-Age(61-80Yrs) |
4.99850050239559E-10 |
| Normal-vs-Age(81-100Yrs) |
3.136100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.142400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.107000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.734800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.802010E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.030800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.786200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.397200E-01 |
| Normal-vs-Grade 2 |
2.30529999534212E-08 |
| Normal-vs-Grade 3 |
5.63480040405295E-10 |
| Normal-vs-Grade 4 |
1.31530009106484E-10 |
| Grade 1-vs-Grade 2 |
3.245000E-01 |
| Grade 1-vs-Grade 3 |
2.662400E-01 |
| Grade 1-vs-Grade 4 |
1.291360E-01 |
| Grade 2-vs-Grade 3 |
5.094400E-01 |
| Grade 2-vs-Grade 4 |
2.400000E-02 |
| Grade 3-vs-Grade 4 |
9.494100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.64159999827396E-08 |
| Normal-vs-ccB subtype |
1.96889999859451E-08 |
| ccA subtype-vs-ccB subtype |
8.122400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52570001077379E-09 |
| Normal-vs-N1 |
1.497530E-02 |
| N0-vs-N1 |
4.536600E-01 |
|
|
